OA08652A - Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus. - Google Patents

Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.

Info

Publication number
OA08652A
OA08652A OA59183A OA59183A OA08652A OA 08652 A OA08652 A OA 08652A OA 59183 A OA59183 A OA 59183A OA 59183 A OA59183 A OA 59183A OA 08652 A OA08652 A OA 08652A
Authority
OA
OAPI
Prior art keywords
virus
vaccine
diagnosing
compositions
producing
Prior art date
Application number
OA59183A
Other languages
French (fr)
Inventor
Shriver Mary Kathleen
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Mcclure Janela
George J Todaro
Robert C Nowinski
Original Assignee
Soc D L Etat De Delaware Genet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D L Etat De Delaware Genet filed Critical Soc D L Etat De Delaware Genet
Publication of OA08652A publication Critical patent/OA08652A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA59183A 1986-08-20 1987-08-28 Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus. OA08652A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (1)

Publication Number Publication Date
OA08652A true OA08652A (en) 1988-11-30

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59183A OA08652A (en) 1986-08-20 1987-08-28 Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
JP2520464B2 (en) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Monoclonal antibody that neutralizes HIV-1
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
WO1989007112A1 (en) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Inducement of protective action against virus infection by synergism between peptides cor- responding to virus envelope glycoprotein and neutral epitope of its glycoprotein
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
ES2222625T3 (en) * 1992-03-27 2005-02-01 Advanced Immuni T, Inc. PEPTIDE T AND ASSOCIATED PEPTIDES INTENDED FOR THE TREATMENT OF INFLAMMATION INCLUDING MULTIPLE SCLEROSIS.
PT1976548E (en) 2005-12-09 2014-10-13 Vectus Biosystems Ltd Vip fragments and compositions thereof
WO2010026940A1 (en) 2008-09-02 2010-03-11 日本特殊陶業株式会社 Spark plug

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
EP0201540B2 (en) * 1984-10-18 2001-10-31 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
DK171119B1 (en) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
DE3650175T3 (en) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules SYNTHETIC ANTIGENIC TO IDENTIFY AIDS.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ATE108022T1 (en) * 1985-10-24 1994-07-15 Southwest Found Biomed Res SYNTHETIC PEPTIDES AND THEIR USE IN DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
DE3787002T2 (en) * 1986-12-30 1993-11-25 Us Health Synthetic peptides that generate cellular immunity to the AIDS virus and its proteins.

Also Published As

Publication number Publication date
IE872219L (en) 1988-02-20
FI873553A0 (en) 1987-08-17
HU214439B (en) 1998-03-30
NO873495L (en) 1988-02-22
SE506025C2 (en) 1997-11-03
IT8721678A0 (en) 1987-08-19
IT1222518B (en) 1990-09-05
SE8703225D0 (en) 1987-08-19
CS8706136A2 (en) 1990-08-14
PL155084B1 (en) 1991-10-31
NO934897D0 (en) 1993-12-29
FR2603107B1 (en) 1992-04-24
PT85567A (en) 1987-09-01
PT85567B (en) 1991-02-08
ATA208987A (en) 1994-01-15
NO873495D0 (en) 1987-08-19
NO300462B1 (en) 1997-06-02
AT398080B (en) 1994-09-26
NO934897L (en) 1993-12-29
AU7720187A (en) 1988-05-19
YU152587A (en) 1992-09-07
IE60671B1 (en) 1994-08-10
NZ221440A (en) 1991-11-26
PL267401A1 (en) 1988-07-21
KR890002547A (en) 1989-04-10
DK433087D0 (en) 1987-08-19
SE8703225L (en) 1988-02-21
HUT44619A (en) 1988-03-28
GR871298B (en) 1988-01-12
ES2010727A6 (en) 1989-12-01
FR2603107A1 (en) 1988-02-26
GB2196634B (en) 1991-05-15
DE3727703A1 (en) 1988-05-05
AU616156B2 (en) 1991-10-24
LU86972A1 (en) 1988-03-02
NL8701950A (en) 1988-03-16
GB8719587D0 (en) 1987-09-23
CS275838B6 (en) 1992-03-18
DK433087A (en) 1988-02-21
KR920008744B1 (en) 1992-10-09
FI873553A (en) 1988-02-21
IL83580A (en) 1992-11-15
JPS6485928A (en) 1989-03-30
GB2196634A (en) 1988-05-05
ZW15487A1 (en) 1988-09-14
CH675728A5 (en) 1990-10-31
BE1000811A4 (en) 1989-04-11
IL83580A0 (en) 1988-01-31
NO302176B1 (en) 1998-02-02

Similar Documents

Publication Publication Date Title
OA08652A (en) Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.
FI99086B (en) Ultrasonic contrast agents, method of their preparation and their use as diagnostic agents
DZ712A1 (en) New 2-2 iminobisethanol derivatives useful as medicines, intermediates for their preparation and processes for the preparation of these derivatives and intermediates.
FR2291168A1 (en) PROCESS FOR THE PREPARATION OF SOUNDPROOFING AGGLOMERS, AS WELL AS THE STRUCTURES AND PANELS FORMED FROM THESE AGGLOMERS
OA03930A (en) Process for the preparation of azapurinones.
FR2366310A1 (en) PROCESS FOR THE PREPARATION OF CORTICOSTEROIDS
OA04987A (en) Process for the preparation of cyclic tertiary amoebae.
FR2376147A1 (en) BICYCLIC PROSTAGLANDINS, USEFUL IN PARTICULAR AS ANTI-AGGLUTINANTS FOR BLOOD PLATES AND THEIR PREPARATION PROCESS
FR2344629A1 (en) METHOD FOR THE PURIFICATION AND ISOLATION OF HEPATITIS VIRUSES USABLE FOR THE PREPARATION OF A VACCINE
UA45942A (en) 1,3-OXATHYOLANE, ITS DERIVATIVES, METHOD (OPTIONS) OF ITS PREPARATION AND PHARMACEUTICAL COMPOSITION
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
MX9203629A (en) MONOCLONAL ANTIBODIES COMPOSITIONS FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF BACTERIAL INFECTIONS DUE TO GROUP B STREPTOCOCCES.
DE3781652D1 (en) PREPARATION SUITABLE FOR TREATMENT OF COLONAL DISEASES.
FR2355826A1 (en) PROCESS FOR THE PREPARATION OF 2,6-XYLYLIDE HYDROCHLORIDE FROM N-METHYL-PIPERIDINE-2-CARBOXYLIC ACID
ATE125870T1 (en) HIV-SPECIFIC MONOCLONAL ANTIBODIES AND HYBRIDOMAS FOR THEIR PRODUCTION.
FR2277891A1 (en) METHOD TO DETECT BY RADIO-IMMUNOMETRY THE PRESENCE OF ANTIBODIES OF BLENNORRHAGIA
DZ1407A1 (en) D-substituted derivatives of n, n'-ditrimethoxybenzoylepiperazine as well as their preparation process.
FR2619220B1 (en) SPECIFIC ANTIGENS OF LEISHMANIA AND THEIR PREPARATION METHOD, ANTIGENIC PROFILES CONTAINING THESE ANTIGENS AND THEIR APPLICATION TO THE DIAGNOSIS OF VISCERAL LEISHMANIOSES.
ATE132374T1 (en) PREVENTION AND TREATMENT OF RETROVIRAL DISEASE
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
FR2296640A1 (en) PROCESS FOR THE PREPARATION OF A-BROMOISOPROPYLIDENE 1A, 5A, 4-THIA-2,6-DIAZA (3,2,0) -2 HEPTENE-6 ACETATE 7-ONE OR THEIR ESTERS
ATE4282T1 (en) PROCESS FOR THE MANUFACTURE OF TOXOPLASM PREPARATIONS FOR TOXOPLASMOS DIAGNOSIS AND THE PREPARATIONS SO MADE.
FR2599971B1 (en) PROCESS FOR OBTAINING IMMUNOLOGICAL MODULATORS FOR THE TREATMENT OF IMMUNE DEFICIENCIES CAUSED BY VIRUSES, AND PRODUCT THUS OBTAINED
OA04328A (en) Process for the preparation of 2-alkoxy-5-alkylsul-fonylbenzoque acid.
FR2383970A1 (en) NEW STEROIDS CONSTITUTED BY PROCESS OF STEROID SPIROOXAZOLIDINES, THEIR PREPARATION PROCESS AND MEDICINAL PRODUCTS CONTAINING THEM